Toth Financial Advisory Corp Sorrento Therapeutics, Inc. Transaction History

Toth Financial Advisory Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.24 - $2.33 $372 - $699	-300 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$4.65 - $7.23 $1,395 - $2,169	-300 Reduced 50.0%	300 $1,000
Q3 2021 Oct 20, 2021	SELL	$7.41 - $10.99 $10,003 - $14,836	-1,350 Reduced 69.23%	600 $5,000
Q4 2020 Jan 25, 2021	BUY	$5.76 - $11.95 $1,728 - $3,585	300 Added 18.18%	1,950 $13,000
Q3 2020 Oct 16, 2020	BUY	$6.17 - $18.82 $8,329 - $25,407	1,350 Added 450.0%	1,650 $18,000
Q2 2020 Jul 14, 2020	BUY	$1.73 - $6.76 $519 - $2,028	300 New	300 $1,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.